financingLabGenius raises £35m to expand its antibody discovery platformLatest NewsLondon-based AI-driven antibody drug discovery specialist LabGenius Ltd has closed a £35m Series B financing round. Read more 21 May 2024 https://european-biotechnology.com/wp-content/uploads/2024/06/Labmate-currency-2317703_1280.jpg 858 1280 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-05-21 22:31:342024-07-08 11:11:56LabGenius raises £35m to expand its antibody discovery platform